Interpreting blood–brain barrier bypass claims in reperfused stroke: a minimum reporting framework for intracalvarial immune-assisted nanoparticle delivery - Takeaways - MDSpire

Interpreting blood–brain barrier bypass claims in reperfused stroke: a minimum reporting framework for intracalvarial immune-assisted nanoparticle delivery

  • By

  • Dandan Liu

  • Hezhong Ouyang

  • Xiaojin Wei

  • Zhengwei Chen

  • Shiyao Zhang

  • Fuling Yan

  • June 19, 2026

  • 0 min

Share

  • 1

    Skull-associated immunity and vascular channels alter the understanding of neuroimmune trafficking in the central nervous system.

  • 2

    Intracalvarial delivery targets local immune cells and vascular channels, potentially enhancing drug delivery in stroke.

  • 3

    Increased nanoparticle signal in reperfused stroke does not confirm blood-brain barrier bypass without further evidence.

  • 4

    A reporting framework is proposed to clarify the evidence required before using strict blood-brain barrier bypass terminology.

  • 5

    Minimum reporting domains include timing alignment, compartment localization, and exposure assessment for accurate interpretation.

Original Source(s)

Interpreting blood–brain barrier bypass claims in reperfused stroke: a minimum reporting framework for intracalvarial immune-assisted nanoparticle delivery

  • by Dandan Liu, Hezhong Ouyang, Xiaojin Wei, Zhengwei Chen, Shiyao Zhang, Fuling Yan

  • June 19, 2026

Related Content

Enhancing motor function after stroke: a systematic review and meta-analysis of bioelectrical feedback interventions

Suicidal ideation after stroke: why standardized screening is essential for community-based prediction models

Telerehabilitation in Community Stroke Services: Mixed Methods Evaluation of Current Practice and Lessons for Sustained Use